Our results displayed that CP-25 is not only as an immune response modulator in ConA-induced hepatitis, but restraining of inflammatory cytokines release may through down-regulating ROS influenced MAPK pathways activation and NF-κB nuclear translocation. Here, NFKB1 is linked to hepatitis A virus infection.